Cancer Research UK Manchester Institute Fellow

Location
Manchester, Greater Manchester
Posted
17 May 2017
Closes
14 Jun 2017
Ref
MI/17/26
Career Level
Consultant
Contract Type
Permanent
Hours
Full Time

cancer research 1          cancer research 2

The Cancer Research UK Manchester Institute

Cancer Research UK Manchester Institute Fellow & Honorary Consultant in Respiratory Medicine if a clinical appointee

•    Job Ref: MI/17/26
•    Salary Scale:

  •  Non-Clinical Salary Scale: £43,000 - £71,700 (depending on relevant experience)
  •  Clinical Salary Scale: £76,761 - £103,490 (depending on clinical seniority)

•    Funding: up to five years 
•    Hours: full-time
•    Expected start date: as soon as possible

The Cancer Research UK Manchester Institute (CRUK MI) (www.cruk.manchester.ac.uk) is seeking an Institute Fellow to join the CRUK Lung Cancer Centre of Excellence (led in Manchester by Professor Caroline Dive and at University College London (UCL) by Professor Charles Swanton). We wish to recruit an outstanding individual, to be based within the CRUK Manchester Institute, who, as a step towards independence, will establish a vigorous and ambitious research programme within the Lung Cancer Centre’s Early Detection and Early Disease Theme. We welcome applications from highly motivated and innovative individuals who are keen to communicate well-formulated research proposals. 

The successful applicant will have a PhD in a relevant area of cancer biology, appropriate post-doctoral training, and a proven track record demonstrated through high-impact publications. We seek applications from clinically and non-clinically trained individuals. If a clinical appointee, the successful applicant will also hold an Honorary Consultant appointment at University Hospital of South Manchester NHS Trust (UHSM). 

The post is funded for up to five years, subject to a quality review at three years, and the generous package includes:

•    Lung Cancer Centre support for their own salary and that of a technical support post with associated running costs.
•    A CRUK MI-funded PhD student (four years).
•    Opportunity to bid for a CRUK Manchester Centre lung cancer ‘ring-fenced’ clinical fellow (four years).
•    Competitive salary range (depending on relevant experience).
•    High quality laboratory space within Professor Dive’s Clinical and Experimental Pharmacology (CEP) Group at CRUK MI.
•    Excellent Institute core facilities.

Informal enquiries can be addressed to Professor Caroline Dive, Deputy Director of the CRUK MI via email: caroline.dive@cruk.manchester.ac.uk 

To obtain the Further Particulars for this position please email: jobs@cruk.manchester.ac.uk 

The CRUK MI is a centre for excellence in cancer research. We occupy state-of-the-art laboratories and provide exceptional core facilities, including next generation sequencing, mass-spectrometry, advanced imaging, bioinformatics, histology, and flow cytometry. We are core-funded by CRUK (www.cancerresearchuk.org), the world’s largest cancer organisation, are an Institute of The University of Manchester (www.manchester.ac.uk), and are adjacent to The Christie NHS Foundation Trust (www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes in a dynamic city surrounded by beautiful countryside and with excellent national and international transport links.

The CRUK Lung Cancer Centre of Excellence is based both in Manchester and at UCL (www.cruklungcentre.org) and is comprised of integrated research themes in Early Detection and Early Disease (led by Dr Phil Crosbie in Manchester and Professor Sam Janes at UCL, and where the post holder will be a member), Biomarkers, Tumour Heterogeneity, Bioinformatics, Basic Research, Immunology, Advanced Radiotherapy and Radiation Research and Clinical Trials. The post holder will benefit from interactions with our Centre’s sister site at UCL, specialising in lung cancer pathogenesis and the development of novel therapies to treat early disease, and with an interest in the mechanisms controlling cell fate decisions and defining whether it is failure of control of these cells that causes early lung cancer lesions. The post holder will also benefit from integration within Manchester’s Centre for Cancer Biomarker Sciences within the Institute’s CEP Group, specialising in liquid biopsies (www.cruk.manchester.ac.uk/Research/CRUK-MI-Groups/CEP/Home). Research collaborations would be anticipated and welcomed with clinical colleagues at UHSM, specialising in Chronic Obstructive Pulmonary Disease Research and lung cancer screening (www.uhsm.nhs.uk/about/research/thoracic-hub), with the Manchester Collaborative Centre for Inflammation Research (www.mccir.ls.manchester.ac.uk), and with the Stoller Centre for Biomarker Discovery (www.biomarkers.manchester.ac.uk/about/sbdc), together providing a highly fertile ground for the research programme of the successful applicant.

To apply for this post please send a CV, the names of three referees, a short summary of past research and a short research proposal (where possible in Adobe PDF format). Please submit your application to the HR Department, by clicking on the apply button or telephone +44 (0)161 306 0841) quoting the job reference number above.

You will also be required to complete an equal opportunities form and a CV cover sheet, these documents will be emailed to you once we have received your application.  

Closing date for applications: 14 June 2017.